Pharma Capsules - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharma Capsules

Pharmaceutical Technology


Lancaster Laboratories Purchases Microchem Laboratories

Lancaster Laboratories (Lancaster, PA) acquired Microchem Laboratories (Waterford, Ireland). Microchem was established in 1986 and is one of Ireland's testing and research laboratories. Microchem offers microbiological, chemical, and environmental analyses to the pharmaceutical, medical-device, and chemical industries in Europe and Asia.

Aptuit Acquires Evotec's Development Business

Aptuit (Greenwich, CT) agreed to acquire Evotec's (Hamburg, Germany) chemical and pharmaceutical development (CPD) business. Evotec's CPD business comprises an active pharmaceutical ingredient (API) facility in Oxford, United Kingdom, and a parenteral fill–finish facility in Glasgow, United Kingdom. The deal provides Aptuit with an established European presence in API development services with more than 80 clients. Aptuit expects the transaction to generate more than $40 million in revenue before the end of 2007.

Gaylord Chemical Co. Buys Gaylord Chemical Corp.

Gaylord Chemical Co. (Slidell, LA) acquired the assets of Gaylord Chemical Corp. (Slidell, LA). Gaylord Chemical Co. comprises the former management team of Gaylord Chemical Corp., a wholly-owned subsidiary of Temple-Inland (Austin, TX). The new owners began operating the combined company on September 1, 2007 under the name Gaylord Chemical Company. Gaylord Chemical Company has manufactured dimethyl sulfide and dimethyl sulfoxide at its Bogalusa, Louisiana, location since 1961.


AAIPharma Expands Management Team

AAIPharma (Wilmington, NC) hired Lee Karras as senior vice-president of nonclinical services and Anne Wiles as senior vice-president of data systems and processes.

Karras will build an infrastructure for the company's North American nonclinical business. Most recently, he served as a consultant for pharmaceutical and biotechnology companies in the areas of technical operations, FDA compliance, supply-chain operations, and strategic planning.

Wiles will advance AAIPharma 's clinical processes and technologies worldwide. She formerly served as president of INC DataSpectrum, the data-services subsidiary of INC Research.

Austin Chemical Elects Chairman and CEO

Austin Chemical Company (Buffalo Grove, IL) elected Samuel M. Ponticelli its new chairman and chief executive officer. Ponticelli's election follows the departure of cofounder Patrick J. Corboy and Iver J. Berry, a partner. President Michael S. Phillips and Vice-President of Operations Joseph J. Chivini will remain with the company.

Ponticelli previously left Austin Chemical Company to form SMP Chemicals. He had served for 25 years as Austin's vice-president of commercial development.


Bilcare Upgrades Facilities

Bilcare (Phoenixville, PA), a global clinical-services firm, is upgrading its packaging, storage, and distribution facilities at its US headquarters. The initial phase of the project includes a complete overhaul of each of the company's packaging rooms. The second phase of the project is the expansion of Bilcare's storage and distribution facility to 72,000 ft2 and the construction of four new secondary packaging rooms.

Bilcare provides clinical-trial materials, support, services, and project management services to the Americas, Europe, and Asia.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here